ISSN 1662-4009 (online)

ey0019.8-14 | Reviews | ESPEYB19

8.14. Should Dehydroepiandrosterone be administered to women?

ME Wierman , K Kiseljak-Vassiliades

J Clin Endocrinol Metab. 2022; 107(6): 1679-1685. PMID: 35254428https://pubmed.ncbi.nlm.nih.gov/35254428/Brief Summary: This review summarizes the evidence on the potential benefits and risks of androgen prohormones, such as dehydroepiandrosterone (DHEA), in normal women and those with DHEA-deficient states.Physiologically, the concentrations of DHEA and DHEAS increase...